First Deputy Chief of Staff of the Presidential Executive Office
Information and Analytical System
Sergei Kiriyenko
Vitaly Mutko
General Director DOM.RF
Marianne Laigneau
Group Executive Director in Charge of International Direction, EDF; Chairwoman of the Supervisory Board, Enedis
Artem Korolev
Director, Nadezhnaya Smena Charity Foundation
Natalya Kozhina
Acting Chairman of the Executive Board, Union of Cement Producers (Soyuzcement)
Vladimir Loginov
Deputy Minister of Natural Resources and Environment of the Russian Federation
Our platform allows you to showcase your goods and services, find investors, colleagues and partners, expand your market and supply chain, create new companies, and opt into already existing projects.
The Regional Best Practices project aims to collect, exchange, and implement proven and effective best practices. The practices themselves are simple measures that can easily be implemented in new regions.
We are bringing together global best practices to shine a light on how people are fighting the pandemic and supporting economies around the world, including through state support, local measures, business initiatives, and citizens’ initiatives.
Pharmaceutical industry
Policies, practices, human capital, technologies and strategies that are reshaping the sector, with particular attention to its impact on general healthcare markets.
Synopsis on the topic
Article
31.10.2019
Development Potential of the Pharmaceutical Industry in BRICS Countries
The paper analyses the main development trends of the pharmaceutical market in the BRICS countries. The main challenges and relevant tasks in the pharmaceutical industry of the BRICS countries are defined. Correspondent solutions providing maximum satisfaction of all involved parties, aimed at further successful development of the BRICS pharmaceutical market are proposed. The forecast for the pharmaceutical industry of the BRICS counties development is presented.
Research
16.04.2019
Russian Pharmaceutical Market 2017
DSM Group has published its annual report where it describes the current state of the pharmaceutical market, reviews main legislative initiatives in the sector, and presents national pharmaceutical ratings for 2017.